Source: 4-TRADERS

ISOCHEM: AURELIUS : subsidiary ISOCHEM growing after reorientation

(4-traders.com) 30 percent sales growth in 2015 Investments in new production facility Munich, July 21, 2015 - The strategy of refocusing on the pharmaceutical business with an emphasis on customer-specific syntheses is bearing fruit for AURELIUS subsidiary ISOCHEM....http://www.4-traders.com/AURELIUS-AG-494695/news/AURELIUS--subsidiary-ISOCHEM-growing-after-reorientation-20719431/

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

CEO

Thierry Malfroot

CEO Approval Rating

70/100

Read more